Medicine & Life Sciences
Breast Neoplasms
100%
Neoplasms
37%
Tamoxifen
37%
Melanoma
37%
Aromatase Inhibitors
26%
Survival
26%
Drug Therapy
25%
Trastuzumab
22%
Therapeutics
22%
Recurrence
21%
Estrogen Receptors
21%
Letrozole
18%
Progression-Free Survival
17%
Cytochrome P-450 CYP2D6
16%
Anastrozole
15%
Triple Negative Breast Neoplasms
15%
Neoadjuvant Therapy
14%
Carboplatin
14%
Paclitaxel
14%
pazopanib
13%
Breast
11%
Aromatase
11%
Cyclophosphamide
11%
Doxorubicin
10%
Breast Density
10%
Disease-Free Survival
10%
Confidence Intervals
10%
Radiotherapy
10%
4-hydroxy-N-desmethyltamoxifen
9%
Fulvestrant
9%
Polyurethanes
9%
Carcinoma
9%
exemestane
8%
Heterografts
8%
Neoplasm Metastasis
8%
Adjuvant Chemotherapy
8%
Multiple Myeloma
8%
Biopsy
7%
Estrogens
7%
Clinical Trials
7%
Serum
7%
Sentinel Lymph Node
7%
130-nm albumin-bound paclitaxel
7%
Lymph Node Excision
7%
Lead
7%
Anaplastic Thyroid Carcinoma
6%
human ERBB2 protein
6%
Tumor Biomarkers
6%
Meningioma
6%
Endometrial Neoplasms
6%